THE ADVISORY BOARD COMPANY Stock – Fundamental Analysis

Price
–
–
Delisted
Reason: Not specified Delisting date: –

Not enough price data available yet.

Fundamental Data & Ratios (Balance sheet update: 3/16/2017)

Balance Sheet Total Assets 2,036,880,000.00 ROE –
Balance Sheet Total Equity 517,044,000.00 ROA –
Cashflow Capital Expenditures -49,000,000.00 P/FCF –
Cashflow Free Cash Flow 63,559,000.00 – –
Cashflow Operating Cash Flow 112,559,000.00 P/CF –
Income Earnings per Share (diluted) 2.23 Div. Yield –
Income Net Income 91,238,000.00 P/E –
Income Shares Outstanding 40,871,000.00 P/B –
Income Total Revenue 803,424,000.00 P/S –

Ratios calculated on: –

Company Description

The Advisory Board Companyprovides best practices research and analysis, software tools, and management and advisory services to the health care and education industries. The Company offers programs rooted in best practices in three key areas: best practices research, software tools and management and advisory services. Its management and advisory services programs assist member institutions efforts to adopt and implement practices to improve their own performance. The Company´s membership-based model, in which members participate in its research and analysis on an annual basis, is central to its strategy. This model gives it privileged access to its members business practices and strategic plans and enables it to provide detailed best practices analyses on current industry issues. The programs offer a standardized set of services, allowing it to spread its fixed program cost structure across its membership base of participating organizations.

Advanced Analysis Features

Additional comparison and history views are available after login.

Finanzoo GmbH assumes no liability for the accuracy of the information provided! All information is provided without guarantee. Sources: www.bundesanzeiger.de, www.sec.gov, www.advisory.com
All metrics and scores are an automated evaluation and not investment advice or a recommendation to buy or sell. Finanzoo GmbH or its shareholders may themselves hold positions in the securities shown. Learn more